Overview

Study of Pharmacology of 17-OHPC in Pregnancy

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
We are examining the pharmacology of 17-OHPC in pregnancy, specifically between the second and third trimesters.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pittsburgh
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institutes of Health (NIH)
Treatments:
11-hydroxyprogesterone
17 alpha-Hydroxyprogesterone Caproate
17-alpha-hydroxy-progesterone caproate